Work

Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease

Year: 2007

Type: review

Source: Clinical and Experimental Nephrology

DOI: 10.1007/s10157-007-0471-x

Authors: Seiji Ueda, Sho-ichi Yamagishi, Yuriko Matsumoto, Kei Fukami, Seiya Okuda

Institution: Kurume University

Language: English

Topic: Nitric Oxide and Endothelin Effects

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2028295746

FWCI: 0.551

Cites: 93

Cited by: 63

Related to: 10